# CellFE: Biotechnology, Alameda, United States

> CellFE: CellFE is a biotechnology and life sciences tools company based in Alameda, California. Based in Alameda, United States. Founded 2018.

Source: https://millionrounds.com/startup/cellfe (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# CellFE

CellFE is a biotechnology and life sciences tools company based in Alameda, California.

Funding reported Last round: Series A

Biotechnology Alameda, United States

Company summary

- **Founded:** 2018 8 years old
- **Team:** 20 11 to 50 people
- **Funding reported:** $27M in dollars
- **Last round:** Series A Sept 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for CellFE has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About CellFE

CellFE is a biotechnology and life sciences tools company based in Alameda, California.

Founded in 2018, the company focuses on a microfluidics-based cell engineering platform aimed at enhancing the development and manufacturing of advanced cell therapies. Led by CEO Alla Zamarayeva, Ph.D., CellFE is dedicated to making lifesaving cell therapies more accessible by addressing key challenges in therapeutic cell engineering, particularly in delivering gene-editing molecules into cells while maintaining cell viability. The company's primary product is a microfluidic device designed for non-viral, non-electroporative intracellular gene delivery. This platform efficiently transports hard-to-deliver molecules, such as large DNA sequences and mRNA, into cells, supporting rapid genome editing and streamlining manufacturing processes. CellFE's technology is particularly beneficial for T-cell therapies, hematopoietic stem cells, and iPSC-based therapies, offering significant advantages in scalability, automation, and cost reduction. The company operates a B2B model, collaborating with pharmaceutical and biotech companies, as well as translational medicine centers, to advance cell therapy research and development.

## What company datasets say CellFE raised

Funding, as reported

Reported in all **$27M** in dollars

Rounds **3**

Last round **Series A**

Last round size **$22M**

Last round date **Sept 2023**

Investors listed **11**

## Founders and team

From CellFE's own website: 1 founder, 3 on the team.

**Avid Motorcycle Explorer** CSO & Co-founder

- **Leo Fomin** VP of Product Development
- **Paul Carman** Head of Commercial
- **Mike Rice** Independent Board Member

## On 3 portfolio pages

Investors who name them

- [GreatPoint Ventures](https://millionrounds.com/fund/greatpoint-ventures)
- [Dynamk Capital](https://millionrounds.com/fund/dynamk-capital)
- [Embark Ventures](https://millionrounds.com/fund/embark-ventures)

Each firm lists CellFE on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

mrna health care gentle cell processing high throughput technology distribution manufacturing high yield cell processing cell therapy cell engineering process scalability cell therapies ryva system microfluidic gene editing bioprocessing hospital & health care non-viral delivery

Built with from their website

WP Engine Hubspot GoDaddy Domains Wordpress Microsoft Exchange Online Microsoft Exchange Microsoft 365 Dassault SOLIDWORKS MySQL Outlook

+6 more

Microsoft 365 Apps & Services PHP Microsoft Email Providers GoDaddy Hosting COMSOL Google Search Console

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, 339112, SIC 3829, 8731, 3841
- **Region:** California
- **Revenue:** $2.2M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/cellfe)

## Biotechnology in United States

Startups like it

- [**National Resilience** founded 2020 *Raised*](https://millionrounds.com/company/national-resilience)
- [**CREATE Medicines** Cambridge · founded 2019 *Raised*](https://millionrounds.com/company/create-medicines)
- [**AusperBio Therapeutics** Startup *Raised*](https://millionrounds.com/company/ausperbio-therapeutics)
- [**City Therapeutics** Startup *Raised*](https://millionrounds.com/company/city-therapeutics)
- [**Nohla Therapeutics** Seattle · founded 2015 *Raised*](https://millionrounds.com/company/nohla-therapeutics)
- [**Genapsys** Redwood City · founded 2010 *Raised*](https://millionrounds.com/company/genapsys)
- [**Proxima Bio** Startup *Raised*](https://millionrounds.com/company/proxima-bio)
- [**Infinimmune** Alameda · founded 2022 *Raised*](https://millionrounds.com/company/infinimmune)

## Is this your company?

Add your raise, your deck and your story, and put CellFE in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)